Uorstiešonys prognoze, kū sauc ari par nātreni, atsaškir atkareibā nu slimeibys tipa i cālūņa.
Akūtajai nātrenejai, kas ilgst mozuok kai sešys nedelis, parostai ir izcyla prognoze, leluokajā daļā gadīņu tei izzūd 24 stuņžu laikā, epizodis reši atsagrīž.
Hroniskajai nātrenejai, kas ilgst vaira kai sešys nedelis, ir drūsuoka prognoze i ir atkareiga nu slimeibys, kas izraisa nātreni, kai ari atbiļdis iz terapiju.
Prognoze hroniskuos nātreneibys gadīņūs ir gryušuok prognozejama, partū ka daži pacienti var sasnēgt remiseju, bet cytim var byut pastuoveigs voi atkuortuots kurss.
Prognoze parostai ir labvieleiga, tok dažūs gadīņūs tū var ītekmēt slimeiba voi autoimunu saslimšonys.
Svareigi, kab pacienti stypri sasadorbuot ar sovu uorstu, kab kontrolātu sovu slimeibu i kontrolātu simptomus, kab īgiutu lobuokūs rezultatus.
Lewis HM, Winter E, Darbyshire P, Yoong A, Marsden JR, Moss C: Urticaria pigmentosa and acute lymphoblastic leukaemia. J R Soc Med. 1995, 88 (9): 530P-531P.
Haas N, Birkle-Berlinger W, Henz BM: Prognosis of acute urticaria in children. Acta Derm Venereol. 2005, 85 (1): 74-5.
Botto NC, Warshaw EM: Solar urticaria. J Am Acad Dermatol. 2008, 59 (6): 909-20; quiz 921-2.
Greiwe J, Bernstein JA: Approach to the Patient with Hives. Med Clin North Am. 2020, 104 (1): 15-24.
Engstrom J, Neher JO, St Anna L: Clinical Inquiry. What is the prognosis for patients with chronic urticaria? J Fam Pract. 2011, 60 (3): 168a-b.
Tanaka T, Hiragun M, Hide M, Hiragun T: [ANALYSIS OF PRIMARY TREATMENT AND PROGNOSIS OF SPONTANEOUS URTICARIA IN A LOCAL CLINIC OF OFFICE DERMATOLOGY]. Arerugi. 2015, 64 (9): 1261-8.
['Atsaceišona nu: medicinys']
['Itei interneta vītne ir dūmuota tikai izgleiteibys i informacejis īmeslim, i tei nateik skaiteita par medicinys pīduovuojumu voi profesionalu pakolpuojumu.']
['Pīduovuotū informaceju nadreikst lītuot, kab diagnosticātu voi izuorstātu kaidu slimeibu, i tim, kas meklej personeigu mediciniskū padūmu, juosazynoj ar licencātu uorstu.']
['Juopīzeist, ka neironu teikls, kas generej atbiļdis iz vaicuojumim, ir eipaši napareizs, kod runoj par skaitliskū saturu, par pīmāru, par konkretu slimeibu diagnozātūs cylvāku skaitu.']
['Vysod meklejit padumu nu sova uorsta voi cyta kvalificāta uorsta, kab saprostu jiusu slimeibu. Nikod naatsakuortojit profesionalū uorsta padumu voi aizkavejit tū mekliešonu deļtuo, ka esat koč kū izlasiejs itamā interneta vītnē. Ka jiusim ruodīs, ka jiusim var byut uorsteibys uorkuortys situaceja, zvaniet 911 voi īīt tyvuokajā uorstnīceibys centrā.']
['Atsaceišona: autortiesības']
['1998. goda Digitaluo tyukstūšgadis autoru tīseibu lykums, 17 U.S.C. § 512 (DMCA) nūdrūsynoj tīseibu aizstuoviešonu autoru tīseibu turātuojim, kuri skaita, ka materialā, kas pasaruoda iz škārsteikla, ir puorkuoptys jūs tīseibys saskaņā ar ASV autoru tīseibu lykumim. ']
['Ka jius iz lobu tycat, ka kaids saturs voi materials, kas ir pīejams saisteibā ar myusu sātom voi pakolpuojumim, puorkuop jiusu autortiesības, jius (voi jiusu aģents) jiusim var syuteit paziņuojumu, kurā lyugts svīgt itū saturu voi materialu voi bloķēt pīeju tam.']
['Paziņuojumi ir juonūsyuta e-postā (vērtīs sadaļu "Kontakti" e-posta adresei).']
['DMCA prasej, kab jiusu paziņuojumā par īspiejamu autortiesību puorkuopumu byutu īkļauta itei informaceja: (1) ar autortiesībām aizsorguotuo dorba aproksts, kas ir īspiejamuos puorkuopuma objekts; (2) īspiejamuos puorkuopuma satura aproksts i informaceja, kas ir pīteikama, kab ļautu mums atrast saturu; (3) jiusu kontaktinformaceja, tymā skaitā adrese, telefona numurs i e-posta adrese; (4) apstyprynuojums, ka jius asat puorlīcynuots, ka saturs tai, kai ir ībyldts, nav atļauts ar autortiesību eipašnīka voi juo aģenta voi kaida lykuma atbolstu; ']
['5. aplīcynuojumu, ka jiusu informaceja ir pareiza i ka jiusim ir tīseibys izmontuot autortīseibys, kuruos ir nūlīgts lītuot;']
['i 6) fizisks voi elektronisks autortīseibu turātuoja voi personas, kas ir pilnvarota dorbuotīs autortīseibu turātuoja vuordā, paraksts.']
['Lyudzu, syutiet mums e-postu ar sevkuru vaicuojumu/ieteikumu.']
What is prognosis of urticaria?
The prognosis of urticaria, also known as hives, varies depending on the type and cause of the condition.
Acute urticaria, which lasts less than six weeks, generally has an excellent prognosis, with most cases resolving within 24 hours and episodes rarely recurring.
Chronic urticaria, which lasts more than six weeks, has a more guarded prognosis and depends on the comorbid disease causing the urticaria, as well as the response to therapy.
The prognosis in chronic urticaria is more difficult to predict, as some patients may experience remission, while others may have a persistent or recurrent course.
The prognosis is generally favorable, but in some cases, it may be affected by the underlying medical condition or the presence of autoimmune disorders.
It is important for patients to work closely with their healthcare provider to manage their condition and monitor their symptoms for the best possible outcome.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
